Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00304434 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.
A Phase 4 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 4
- Development phase
- 48
- Enrollment target
NCT00304434 is a Phase 4 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 48 participants.
The verdict
NCT00304434, a Phase 4 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 48 participants
- Enrollment target
Study Summary
Objective 1: Determine the safety and toxicity profile of Tamiflu administered in combination with probenecid in healthy adults.Objective 2: Determine the pharmacokinetic profile of Tamiflu and probenecid in healthy adults.
Interventions
- DRUG Probenecid
- DRUG Oseltamivir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2005-02 |
| Est. Completion | 2007-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00304434
The ClinicalTrials.gov registry entry for NCT00304434 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Probenecid is the first listed.
NCT00304434 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00304434 about?
NCT00304434 is a clinical study titled "Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.". Objective 1: Determine the safety and toxicity profile of Tamiflu administered in combination with probenecid in healthy adults.Objective 2: Determine the pharmacokinetic profile of Tamiflu and probenecid in healthy adults.
What is the current status of trial NCT00304434?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2005-02. Estimated completion is 2007-02.
What interventions are being tested in trial NCT00304434?
The interventions under investigation include: Probenecid (DRUG), Oseltamivir (DRUG).
Who is sponsoring clinical trial NCT00304434?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.